Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03929237 · ClinicalTrials.gov registry record

When do School-aged Patients Return to School After ACL Surgery?

A clinical trial of ACL Reconstruction, sponsored by St. Louis University.

Completed
Registry status
58
Enrollment target
2
Study locations

NCT03929237 is a study of ACL Reconstruction that has completed, run by St. Louis University. The registered enrollment target is 58 participants, below the 119-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03929237, a study of ACL Reconstruction, has completed, sponsored by St. Louis University.

COMPLETED
Registry status
58 participants
Enrollment target
2
Study locations

Study Summary

We intend to survey school aged patients following ACL surgery on when they return to school. We will analyze independent variables to determine if any relationship exists that may influence the amount of time missed.

Conditions Studied

Interventions

  • OTHER observe when return to school after surgery

Study Locations (2)

Missouri

  • Saint Louis University - St Louis
  • SSM Health Saint Louis University Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2019-04-18
Est. Completion 2021-12-31

Sponsor

St. Louis University

107 total trials

What the Registry Record Tells You About NCT03929237

The ClinicalTrials.gov registry entry for NCT03929237 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (51% lower). The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ACL Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which observe when return to school after surgery is the first listed.

NCT03929237 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03929237 about?

NCT03929237 is a clinical study titled "When do School-aged Patients Return to School After ACL Surgery?". We intend to survey school aged patients following ACL surgery on when they return to school. We will analyze independent variables to determine if any relationship exists that may influence the amount of time missed.

What is the current status of trial NCT03929237?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2019-04-18. Estimated completion is 2021-12-31.

What conditions does trial NCT03929237 study?

This clinical trial studies the following conditions: ACL Reconstruction.

What interventions are being tested in trial NCT03929237?

The interventions under investigation include: observe when return to school after surgery (OTHER).

Who is sponsoring clinical trial NCT03929237?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03929237 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.